is a Chairman & Professor in the Department of Pharmacology and Molecular Therapeutics at the Kumamoto University, Kumamoto, Japan. His research interests are cardiovascular pharmacology, renal pharmacology, clinical pharmacology, the pathophysiology of hypertension, the pathophysiological role of the renin-angiotensin system, and gene therapy.
is the Ashland Chair in Chemical Engineering and Professor of Chemical & Materials Engineering and Pharmaceutical Sciences at the University of Kentucky. His research interests include development and investigating mechanisms of controlled-release systems, nanobiotechnology for drug delivery and imaging, and design of materials for non-viral DNA and siRNA delivery.
is the William Farish endowed chair in nanobiotechnology and Director of Nanobiotechnology Center in University of Kentucky. He also serves as the director of NCI Cancer Nanotechnology Platform Partnership Program: RNA Nanotechnology for Cancer Therapy.
is a Director in the School of Pharmacy, University of Zimbabwe’s College of Health Sciences, South Africa. He earned his Doctorate in Pharmacy from the State University of New York at Buffalo, USA. He is an expert in HIV Clinical Pharmacology, Therapeutics, Clinical Pharmacokinetics. His recent research focuses on novel drug delivery systems including nanotechnology based formulation.
is a Professor of Pharmaceutical Sciences at the College of Pharmacy, University of Kentucky Medical Center. Dr. Lodder holds a joint appointment in the Division of Analytical Chemistry of the Department of Chemistry at Kentucky, as well as a joint appointment in the Department of Electrical and Computer Engineering in the College of Engineering.
is a Professor and Department Chair of Pharmacy Practice and Professor of Pharmaceutical Sciences at Mercer University College of Pharmacy and Health Sciences in Atlanta, Georgia. His research interests include the effects of psychotropic drugs in different ethnic populations, aging, mechanisms of drug interactions, pharmacogenetics, academic detailing, and pharmacotherapy.
is a Professor from Department of Pharmacy, Seoul National University at Korea. His research interests include cell signal transduction underlying for proliferation, adhesion, actin reorganization, epithelial-mesenchymal transition, migration, invasion, morphological changes, and metastasis via actions of integrins, tetraspanins, receptor tyrosine kinases, and other membrane receptors.
is a Professor in the School of Pharmacy at Curtin University, Bentley, WA, Australia. His research interests require a combination of applied pharmaceutical research, pharmacology, and biomedical sciences, and his major disease focus is cancer. His research expertise lies in in silico, in vitro, in vivo and post-clinical analyses of both traditional and novel drug candidates.
is a Professor in the Department of Pharmaceutics at Rutgers, The State University of New Jersey and an investigator in Rutgers Cancer Institute of New Jersey. His research interests include design and development of advanced multifunctional and targeted systems for nucleic acid delivery, nanomedicine for cancer therapy and imaging, stem cell engineering for cancer therapy.
is a Professor in the Department of Pharmacology and Neuroscience at University of North Texas Health Science Center at Fort Worth, USA. Since 1995, His research has mainly focused on ischemia research using focal and global ischemic models, specifically on the neuroprotection, neurogenesis and brain repair after ischemia stroke.
is a Professor & Chair of Pharmacology in School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Ireland. A highly-cited pharmacologist who worked both in academia & pharmaceutical industry in Poland, UK, Spain, Canada, USA & now in Ireland. He is interested in platelet regulation, cancer, nitric oxide, as well as in nanomedicine, nanopharmacology & nanotoxicology.
is a Professor of Pharmacology and Toxicology at University of Mississippi Medical Center, USA. His research projects cover microRNAs and long non-coding RNAs, and their roles in tumorigenesis and drug resistance. He is also a member of Cancer Institute at University of Mississippi Medical Center (UMMC).
is a Professor of Pharmacy at College of Pharmacy, Pusan National University in Korea. His research interests are cancer biology with focus on molecular mechanisms of cell death such as apoptosis and autophagy, cell cycle regulation, regulation of hypoxia-induced gene regulation, and developments of chemopreventive and chemotherapeutic agents with synthetic and natural compounds.
is a Dean and Professor of the College of Pharmacy at the University of Sharjah, UAE. His research interests include drug Utilization Studies, classification of Adrenoceptors in isolated tissues, and dependence on and withdrawal from morphine.
is a Professor and Deputy Dean in Faculty of Pharmacy at Universiti Teknologi MARA, Malaysia. Her main current research areas include Clinical Pharmacy Research focus on cardiovascular, renal, critical care and geriatric pharmacy, Pharmacotherapy in critically ill, rational drug use, drug adverse effect and drug-drug Interactions.
is a Professor and Head of the Pharmacy Practice Department at Faculty Pharmacy, Universiti Teknologi MARA (UiTM), Malaysia. His current research interests focus on pharmacoepidemiology, clinical pharmacy and pharmaceutical outcome study. He also serves as a consultant for clinical pharmacokinetic and bioequivalence clinical trials.
is a Regents Professor in the Department of Pharmacology at University of Minnesota Medical School, Minnesota. His research interests are in the areas of molecular neuropharmacology and biochemical pharmacology, mainly specializing in the mechanism of narcotic actions and mechanism of tolerance. His detailed studies are in opioid receptor signaling, regulation of receptor activity & receptor gene cloning.
is a Professor of Pharmaceutics at Faculty of Pharmacy, Omer Al-Mukhtar University, Libya. His area of interest include nanomedicine, nanopharmaceutics, nanobiopharmaceutics, novel drug delivery system, new dosage forms, Intellectual Property Rights (IPR’s) and Regulatory affairs.
is Head of School of Pharmaceutics & an Associate Professor in Faculty of Pharmacy, Universiti Teknologi MARA. He is also chair/founder of Non-Destructive Biomedical & Pharmaceutical Research Centre, & PharmaTech conference & exhibition. His primary research areas are scaffold design for oral & transdermal drug delivery, development of non-destructive pharmaceutical analysers & innovative processors.
is a Professor of Pharmaceutics, Faculty of Pharmacy at Universiti Teknologi Mara, Malaysia. His major research interests are in the areas of Physical pharmacy, Drug delivery systems, Industrial pharmacy and Biopharmaceutics.
is an Associate Professor at Jiangsu Institute of Parasitic Diseases and the Key Laboratory on Technology for Parasitic Disease Prevention and Control, Ministry of Health, the People’s Republic of China. His research interests focus on but are not limited to neglected tropical diseases (NTDs), drug resistance, vector control and epidemiology,immunology of parasitic infections.
is an Associate Professor of Pharmaceutical Sciences at the College of Pharmacy at Mercer University. His expertise lies within the area of molecular pharmacology and signaling of G protein-coupled receptors including medicinal chemistry and discovery of novel drugs which modulate GPCR function.
is an Associate Professor of Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Mercer University College of Pharmacy and Health Sciences, Atlanta, GA . Her expertise resides in preclinical pharmacokinetics, cancer biology and nano-sized drug delivery systems. Her research focuses on the development of novel nanocarriers for targeted cancer therapy.
is an Associate Professor at the Department of Pharmaceutical Sciences at the University of Michigan College of Pharmacy. He is Principal Investigator of the subcellular drug transport laboratory. He is interested in the application of preclinical (in silico, in vitro and in vivo) models to facilitate development of site-directed chemotherapeutic agents.
is an Associate Professor in the Department of Pharmacology of the Yong Loo Lin School of Medicine at the National University of Singapore. His research program is to study the pathogenesis of and to develop mechanism-based pharmacological agents for the treatment of allergy and airway inflammation.
is an Associate Professor in the Department of Pharmaceutics at Virginia Commonwealth University School of Pharmacy, USA. His research encompasses investigations into the impact of organic solute transporters on the permeation of drugs and toxins across barrier epithelia, e.g., kidney, liver, testis, and choroid plexus.
is an Associate Professor in the Department of Pharmacology & Therapeutics at University of Manitoba with a joint appointment in the Department of Psychiatry. His research focuses on understanding how oxidative stress in psychiatric disorders affects neurotransmitter systems & their signalling networks, & identifying targets in the oxidative stress process for pharmacological treatments.
is Associate Professor at the Department of Drug Sciences at the University of Pavia, Italy. His main research deals with cell biology of glial cells and glioma cancer stem cells. His current research focuses on role of integrins and chemokines receptors in attachment and migration of glioma cell lines and glioma cancer stem cells.
is an Associate Professor of Pharmaceutical Sciences at the UNT System College of Pharmacy at Fort Worth and holds joint appointment in the Department Pharmacology and Neuroscience of the Graduate School of Biomedical Sciences, University of North Texas Health Science Center. Her research interests include medicinal chemistry-driven drug design and delivery into the central nervous system.
is an Associate Professor & a Canadian Institute of Health Research New Investigator in the Department of Physiology and Pharmacology, with joint appointment in the Department of Oncology, University of Western Ontario, Canada. Her research focuses on understanding the molecular mechanisms regulating breast cancer metastasis upon activation of G protein-coupled receptors.
is an Associate Professor and Acting Deputy Head of School in Pharmacological Sciences at University of Tasmania, Australia. His particular interest at UTAS is to develop therapies for neuro-degenerative and mitochondrial diseases through collaborations between medicinal chemistry, pre-clinical and clinical sciences.
is an Associate Professor in the Department of Pharmacology & Neuroscience and the Institute of Aging & Alzheimer’s Disease Research at the University of North Texas Health Science Center. His research goals include developing clinically-useful drug therapies that will ameliorate cognitive & autonomic functions in patients with age-, disease- & trauma-related impairments.
is an Associate Professor in the Department of Clinical Pharmacology, College of Medicine, Cairo University, currently working in the University of Sharjah, UAE. Her research interests are pharmacogenomics, cardiovascular drugs, clinical pharmacology & cancer research. Her current project aims at testing new polysubstituted imidazopyridine derivatives as potential anti-cancer agents.
is an Associate Professor with the Faculty of Pharmacy at Universiti Teknologi MARA, Malaysia. She is the Head of MedChem Herbal Research Group since 2005. Her research focuses on the identification of bioactives from herbs and plants, standardisation of herbs and evaluation on the efficacy and safety of herbs.
is an Associate Professor at Faculty of Pharmacy, Universiti Teknologi MARA. His current research focuses on investigating & developing novel RNA-targeted medicinal agents potentially to treat diseases such as AIDS; multidrug resistant bacterial infections. Through structural biology & medicinal chemistry studies, it is hoped to determine the structure-function relationships of novel RNA targets.
is an Associate Professor of Pharmaceutical Chemistry at Thomas J. Long School of Pharmacy and Health Sciences, University of the Pacific in Stockton, California. His research crosses disciplines of Pharmaceutics and Medicinal Chemistry and is focused on developing novel nanoparticulate drug/gene delivery systems such as liposomes.
is an Associate Professor at the Department of Pharmacology & Pharmacy, The University of Hong Kong. Her research mainly focus on molecular pharmacology in obesity and cariometabolic diseases, with an emphasis on adipokine-based drug discovery and development.
is an Associate Professor within the Division of Pharmaceutical Sciences at Arnold and Marie Schwartz College of Pharmacy and Health sciences, Long Island University, Brooklyn, NY. His research interests include pre-formulation and formulation of poorly soluble drugs, powder characterization, oral drug delivery, nanocrystals, nanosuspension and orally dissolving strips.
is an Associate Professor of Pharmaceutical Sciences in the School of Pharmacy, the University of Missouri-Kansas City. His research focuses on the development of novel drug delivery systems for small-molecule & macromolecular drugs, identification of tumor-specific artificial ligands for targeted drug delivery & tumor imaging, therapeutic applications of siRNA for the treatment of breast & prostate cancer, & liver diseases.
is an Associate Professor at the Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, USA. His research interests include formulation development of nanoparticle based formulations for topical and oral delivery, solubility improvement of insoluble drugs, percutaneous penetration enhancement techniques, transdermal drug delivery systems.
currently a scientist at the Robarts Research Institute and an Associate Professor in the Departments of Physiology and Pharmacology and of Medicine at Western University, London, Ontario. The focus of his research programme is to investigate the cellular/ molecular mechanisms involved in the regulation of vascular and cardiac function.
is a Senior Formulation Development Scientist in Par Sterile Products, LLC, USA. His research interest includes Injectable & ophthalmic drug product development, pre-formulation, solubilization techniques, lyophilization, targeted drug delivery, nanoparticulate systems including liposomes, design of experiments, Quality by Design, extractables/leachables, & salt selection/screening.
is an Assistant Professor in the Department of Pharmaceutical & Biomedical Sciences, University of Georgia. He is an expert in the area of neuroscience, including physiology, pharmacology & molecular biology. He is interested in identifying therapeutic targets for treatment of neurological disorders. Currently, his research focuses on the synaptic and molecular mechanisms related to the pathogenesis of pain.
is a Research Assistant Professor in the Department of Pharmaceutical Sciences from Northeastern University. He was awarded the coveted CRS T. Nagai Postdoctoral Research Achievement Award from Controlled Release Society (CRS). His research interests include polymeric biomaterials for drug targeting and development of nanomedical technologies for disease diagnosis, imaging & therapy.
is a Research Assistant Professor in Center for Drug Discovery, Northeastern University, Boston. His research includes drug discovery using biophysical techniques including NMR & computer modeling. Currently, his research focuses on the endocannabinoid system with the emphasis on developing novel molecular probes & potential therapeutics for treating pain, substance abuse & other disorders.
is an Assistant Professor in the Department of Pharmacy & Health Sciences, Mercer University, Georgia, USA. Her Research interests are Health Outcomes, Health Disparities, Pharmacoeconomics/Comparative Effectiveness, Medicare Part D, Geriatrics, Managed Care.
is an Assistant Professor at University of Houston, Texas Medical Center. During his graduate work at CWRU and Cleveland Clinic Foundation, he studied the regulation of ?-adrenergic pathway in hypertrophied & failing hearts. His training also included a postdoctoral fellowship at Harvard Medical School, where he studied human genetic pathologies.
is an Assistant Professor at Department of Molecular Pharmacology & Physiology, University of South Florida Morsani College of Medicine. His research focuses on the discovery and development of novel treatments for acute surgical conditions such as trauma, sepsis and ischemia reperfusion injury.
is an Assistant Professor in the Department of Physical Pharmaceutics at Kumamoto University. His research interests are the importance of formulation design, which is the key technology of enhancing drug efficacy & reduction of side effects, is increasing in the advance of the drugs from low-molecular compounds to peptide/protein, DNA/functional nucleic acid & cytomedicine.
is an Assistant Professor, Department of Pharmacology and Molecular Therapeutics, Graduate School of Medical Sciences, Kumamoto University. He is interested in studying the cardiac pharmacology, cardiac ischemia-reperfusion injury, arrhythmia, and molecular Therapeutics. He is a member of many medical associations, and is a fellow of American Heart Association.
is an Assistant Professor of Pharmaceutics in the Department of Pharmaceutical Sciences, School of Pharmacy, Hampton University. His research interests include Design and synthesis of novel biomaterials for drug delivery, Delivery of small interference (siRNA), oligonucleotides (ODNs), and genes for treating various diseases, Innovative strategies to overcome multiple drug resistance in cancer chemotherapy.
is an Assistant Professor of Pharmaceutical Science and Neuroscience at the University of Wyoming, Laramie, USA. The main focus of the Brown laboratory is determining how exposure to drugs of abuse, traumatic events and painful stimuli ultimately impacts neuroplasticity. Specifically, he is interested in how regulation of the extracellular matrix mediates synaptic organization.
is an Assistant Professor of Pharmaceutics in the Department of Basic Pharmaceutical Sciences, School of Pharmacy, Husson University, USA. His research focuses on the development of nanotechnology incorporated drug delivery systems for sustained and targeted applications.
is an Assistant Professor in the Department of Pharmacokinetics and Phrmacodynamics, School of Pharmaceutical Sciences at University of Shizuoka, Shizuoka, Japan. His research interests are PK/PD analysis based on receptor binding, urological pharmacology, clinical pharmacology.
is an Assistant Professor in the Department of Pharmacology at the Yong Loo Lin School of Medicine, National University of Singapore. His research interests include the elucidation of the biological roles of lipid-activated G protein-coupled receptors (GPCRs) in cancer and other diseases, and the development of GPCR-targeted therapeutic antibodies.
is an Assistant Professor in Department of Pharmacology, National University of Singapore. He is currently leading the Cancer Pharmacology program in the Department of Pharmacology. His research interest mainly includes Mechanism of activation of transcription factor NF-kB by carcinogens and inflammatory agents and Why tumor cells express constitutive active NF-kB.
is an Assistant Professor at the Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore. He is also a Visiting Senior Research Fellow with the Wolfson Centre for Age-Related Diseases, King’s College London, United Kingdom. His research interests include dementia and stroke neurochemistry, biomarkers discovery, and neuroinflammation.
is an Assistant Professor at the Department of Pharmacology & Pharmacy, The University of Hong Kong. His research interest mainly includes novel formulations, pharmaceutical nanotechnology, particle engineering & respiratory drug delivery. He has collaborated with academic and industrial researchers, both locally & internationally, on formulation-focused as well as cross-disciplinary projects.
is an Assistant Professor of Pharmaceutical Chemistry at University of Sharjah, UAE. Over the past 10 years, He has been performing research in drug discovery & development which includes the area like Design & Synthesis of Novel Anti-Cancer Drug leads and Design, synthesis of novel lead compounds for potential drug leads for Alzheimer’s diseases.
is an Assistant Professor in the college of Pharmacy at Dankook University, South Korea. His Research interest includes Brain ischemia, Aging in central nervous system and Endogenous neurogenesis.
is a senior lecturer in the Department of Pharmacy, Faculty of Medicine, University of Malaya. His research crosses disciplines of Pharmaceutics & Pharmacology. In Pharmacology, his research investigates the cellular & molecular modulation of potent compounds & in Pharmaceutics, it is focus in designing polymeric carrier systems to enhance the oral delivery of protein or peptide-based drugs.
is a Lecturer in cellular & Molecular Neuroscience at School of Pharmacy, University of Reading. He has built up an interest in the regulation of ion channels & transporters. His current work is looking at the impact of the so called gasotransmitters on a variety of cell types within the central nervous system.
earned his Doctorate in Pharmacy & Doctorate of Philosophy in Clinical and Experimental Oncology from the University of Florence, Italy. Her research interest is cancer biology, with focus on molecular basis of oncogenic signaling. Dr Cecchi’s work provide insight into strategies aimed at preventing & overcoming acquired drug resistance.
is a Scientist I in Drug Metabolism & Pharmacokinetics at Vertex Pharmaceuticals Inc., in Boston. He worked as aPost Doctoral fellow at the University of Maryland-School of Pharmacy, Baltimore, USA. His research interest includes drug transporter-mediated drug disposition, drug-drug interactions and transporter biology. His interest also includes developing in vitro cell assay platforms for drug transporters.
is an Expert cardiologist in Department of Cardiology, Aksaz Military Hospital, Turkey. He worked at Cardiology Department of Gulhane Military Medical Academy for 4 years. His subject area includes Cardiac imaging, Coronary Angiography, Echocardiography, Cardiomyopathy, Heart failure, Arrhythmia, Electrophysiology, Arterial Stiffness, Hypertension, Hyperlipidemia, Diabetes Mellitus, Obesite.
Senior Research Specialist, University of Tennessee Health Science Center, USA. His research interest focuses design, development and evaluation of conventional and novel drug delivery systems including biodegradable nanoparticles, liposomes, and targeted antibody conjugated nanocarriers, and iron-oxide nanoparticles for cancer therapy.
is Senior Research Specialist in University of Tennessee Health Science Center, Memphis, TN, USA. His research focuses on Sterile Drug Delivery System, Biosimilars, Pharmaceutics, Nanotechnology, Nanoparticle Synthesis.
is a public hospital pharmacist manager from 2008, Italy. He studied Pharm.D in 1995 Sperimental thesis, Turin university. He studied as pharmacologist at Pavia University.
School of Life Sciences Jawaharlal Nehru University, New Delhi, India. His research interest is Biochemical parasitology, Peptides, Infection biology, Microbiology, Immunology, Enzymology, Probiotics, System biology, Molecular biology, Drug targeting.
is a Postdoctoral Research Fellow in Chemistry, California South University (CSU), Irvine, California, USA. His research interests are Biophysical Chemistry, Nanochemistry, Quantum Chemistry, Biomolecular, Vibrational Spectroscopy, Molecular Modeling and Structure, Theoretical, Computational and Mathematical Chemistry, Ab initio and Density Functional Methods.
is currently a research analyst at Belcher Pharmaceuticals, USA. He has been awarded Thomas C. Rumble fellowship of Wayne State University, USA. His research interests include different forms of cancer therapies like Chemotherapy, Radiation therapy and Photodynamic therapy. He is also interested in Oxidative stress, Inflammatory diseases and Cell death pathways like apoptosis.